All podcasts

Biotech and Tick Vectored Disease

Ticks are important disease vectors, spreading Lyme Disease and other human pathogens. New technology permits improved functional genetic research as well as creates a basis for genetic engineering strategies to limit populations or control disease vectoring.

Feb 26, 2022 by Dr. Kevin Folta in Talking Biotech

Apple podcasts link Google podcasts link Spotify podcasts link

Ticks are significant disease vectors, with an emerging scope of pathologies associated with tick bites. New technologies have accelerated the ability to genetically engineer ticks, creating new opportunities to understand gene function in ticks, as well as potentially use gene editing to control numbers or affect disease vectoring. Dr. Monika Gulia-Nuss (University of Nevada, Reno) and Dr. Jason Rasgon (Penn State University) describe tick disease transmission, new transformation technology, and potential applications.

Colabra

Get your whole lab on the same page today.

Learn more